Article info

other Versions

PDF

Extended report
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)

Authors

  1. Correspondence to Professor Jean-Yves Reginster, Department of Public Health, Epidemiology and Health Economics, Liège State University, Liège, Belgium, Quartier Hôpital – CHU B23, venue Hippocrate, 13 , 4000 Liège, Belgium; jyr.ch{at}bluewin.ch
View Full Text

Citation

Reginster J, Dudler J, Blicharski T, et al
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)

Publication history

  • Received 22 November 2016
  • Revised 15 March 2017
  • Accepted 20 March 2017
  • Published in print 20 May 2017.
  • Published online 22 May 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.